查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594391

基于 NGS 的 RNA定序市场：按产品和服务、技术、应用和最终用户划分 - 2025-2030 年全球预测

NGS-Based RNA-Sequencing Market by Product & Services, Technology, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年基于NGS的RNA定序市值为23.2亿美元，预计2024年将达到26.7亿美元，复合年增长率为17.32%，到2030年将达到71.2亿美元，预计将达到1000万美元。

基于 NGS 的 RNA定序能够对转录组进行全面分析，透过提供对基因表现的详细见解、发现新的转录本以及增进对基因调控机制的理解，正在彻底改变基因组学研究。对 RNA定序的需求源于其提供准确、高通量资料的能力，这对于推动个人化医疗、识别新的治疗标靶和理解复杂的生物系统至关重要。应用范围从肿瘤学到神经学，在疾病研究、诊断和药物发现中发挥重要作用。最终用途市场多种多样，包括学术和研究机构、临床诊断实验室、製药公司和生物技术公司，展示了广泛的应用。市场成长受到以下因素的支持：对个人化医疗的日益偏好、基因组研究资金的增加以及测序技术的进步降低了成本并提高了可及性。新兴的商机包括整合人工智慧和机器学习进行资料分析，加强RNA定序在非模型生物和未充分研究的疾病中的应用，以及扩大效用。公司应专注于与研究机构合作，推动创新并探索独特的定序应用。然而，初始成本高、资料复杂性以及对先进基础设施的需求等限制因素为市场扩张带来了挑战。有关遗传资料的监管复杂性和伦理问题使情况更加复杂。创新机会包括推进定序技术以提供更快、更具成本效益的解决方案、开发强大的资料分析工具以简化解释以及用户友好性以实现民主化。随着市场的成熟，利用云端运算进行资料储存和运算将变得至关重要，而策略性产学合作将成为探索新机会的核心。 RNA定序市场充满活力且快速发展，随着它与医学创新和研究的前沿更加契合，其强劲的成长潜力显而易见。

主要市场统计
基准年[2023] 23.2亿美元
预测年份 [2024] 26.7亿美元
预测年份 [2030] 71.2亿美元
复合年增长率（%） 17.32%

市场动态：揭示快速发展的基于 NGS 的 RNA定序市场的关键市场洞察

基于 NGS 的 RNA定序市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 次世代定序仪的快速采用
    • 精准医学的强劲成长和 RNA 定序津贴的增加
    • 对先进的基于序列的诊断的需求不断增长
  • 市场限制因素
    • NGS设备成本高
  • 市场机会
    • RNA定序技术进步
    • 与 RNA定序相关的研究活动增加
  • 市场问题
    • 缺乏熟练人才

波特五力：驾驭基于 NGS 的 RNA定序市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基于 NGS 的 RNA定序市场的外部影响

外部宏观环境因素在塑造基于 NGS 的 RNA定序市场的绩效动态发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解基于NGS的RNA定序市场的竞争格局

基于 NGS 的 RNA定序市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：基于 NGS 的 RNA定序市场供应商绩效评估

FPNV定位矩阵是评估基于NGS的RNA定序市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製基于 NGS 的 RNA定序市场的成功之路

对于想要加强在全球市场的影响力的公司来说，基于 NGS 的 RNA定序市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 次世代定序的快速采用
      • 精准医疗强劲成长，RNA定序津贴增加
      • 对先进的基于序列的诊断的需求不断增长
    • 抑制因素
      • NGS设备成本高
    • 机会
      • RNA定序技术进步
      • 与 RNA定序相关的研究活动增加
    • 任务
      • 缺乏熟练人才
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章基于NGS的RNA定序市场：依产品和服务分类

  • 介绍
  • 资料分析
  • RNA定序平台与用品
  • RNA定序服务
  • 样品製备产品
  • 储存与管理

第七章基于NGS的RNA定序市场：依技术分类

  • 介绍
  • 离子半导体定序
  • 奈米孔定序
  • 合成定定序
  • 单分子即时定序

第八章基于NGS的RNA定序市场：依应用分类

  • 介绍
  • 从头转录组组装
  • 表达谱分析
  • 小规模RNA定序
  • 变异调用和转录组表观遗传学

第 9 章 基于 NGS 的 RNA定序市场：依最终使用者划分

  • 介绍
  • 医院/诊所
  • 製药和生物技术公司
  • 研究和学术

第十章 美洲基于NGS的RNA定序市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区基于NGS的RNA定序市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲基于NGS的RNA定序市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies
  • Becton, Dickinson and Company
  • BGI Group
  • Eurofins Scientific
  • F. Hoffmann-la Roche AG
  • Genewiz by Brooks Automation, Inc.
  • Hamilton Company
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Nanopore Technologies
  • PerkinElmer, Inc.
  • Psomagen
  • Qiagen NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific
Product Code: MRR-2214614769D5

The NGS-Based RNA-Sequencing Market was valued at USD 2.32 billion in 2023, expected to reach USD 2.67 billion in 2024, and is projected to grow at a CAGR of 17.32%, to USD 7.12 billion by 2030.

NGS-Based RNA-Sequencing, which enables comprehensive analysis of the transcriptome, promises to revolutionize genomics research by providing detailed insights into gene expression, discovery of novel transcripts, and enhanced understanding of gene regulation mechanisms. The necessity of RNA-Sequencing arises from its ability to deliver precise, accurate, and high-throughput data essential for advancing personalized medicine, identifying new therapeutic targets, and understanding complex biological systems. Applications span from oncology to neurology, playing a crucial role in disease research, diagnostics, and drug discovery. End-use markets encompass academic and research institutes, clinical diagnostics labs, pharmaceutical and biotech companies, underscoring broad application versatility. Market growth is underpinned by factors such as increasing preference for personalized medicine, growing funding for genomic research, and technological advancements in sequencing technology that drive down costs and improve accessibility. Latest opportunities include integrating AI and machine learning for data analysis, enhancing the application of RNA-Sequencing in non-model organisms and less-studied diseases, and expanding its utility in biomarker discovery and precision medicine. Companies should focus on collaborations with research institutions to drive innovation and explore unique sequencing applications. However, limitations like high initial costs, data complexity, and the requisite for sophisticated infrastructure challenge market expansion. Regulatory complexities and ethical concerns related to genetic data further complicate the landscape. Innovation opportunities lie in advancing sequencing technologies to offer faster and more cost-efficient solutions, developing robust data analysis tools to streamline interpretations, and focusing on user-friendly platforms to democratize access. As the market matures, leveraging cloud computing for data storage and computation will be vital, and strategic industry-academic collaborations will be central to exploring nascent opportunities. The RNA-Sequencing market is dynamic and rapidly evolving, marked by robust growth potential as it aligns increasingly with healthcare innovation and research frontiers.

KEY MARKET STATISTICS
Base Year [2023] USD 2.32 billion
Estimated Year [2024] USD 2.67 billion
Forecast Year [2030] USD 7.12 billion
CAGR (%) 17.32%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving NGS-Based RNA-Sequencing Market

The NGS-Based RNA-Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surge in the adoption of next-generation sequencing
    • Robust growth of precision medicines and rising amount of RNA sequencing grants
    • Increasing demand for advanced sequencing-based diagnostics
  • Market Restraints
    • Cost of NGS instruments is high
  • Market Opportunities
    • Technological advancement in the RNA-Sequencing
    • Increasing research activities related to RNA-Sequencing
  • Market Challenges
    • Unavailability of skilled manpower

Porter's Five Forces: A Strategic Tool for Navigating the NGS-Based RNA-Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the NGS-Based RNA-Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the NGS-Based RNA-Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the NGS-Based RNA-Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the NGS-Based RNA-Sequencing Market

A detailed market share analysis in the NGS-Based RNA-Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the NGS-Based RNA-Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the NGS-Based RNA-Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the NGS-Based RNA-Sequencing Market

A strategic analysis of the NGS-Based RNA-Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the NGS-Based RNA-Sequencing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Becton, Dickinson and Company, BGI Group, Eurofins Scientific, F. Hoffmann-la Roche AG, Genewiz by Brooks Automation, Inc., Hamilton Company, Illumina, Inc., Merck KGaA, Oxford Nanopore Technologies, PerkinElmer, Inc., Psomagen, Qiagen N.V., Takara Bio Inc., and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the NGS-Based RNA-Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Services, market is studied across Data Analysis, RNA Sequencing Platforms & Consumables, RNA Sequencing Services, Sample Preparation Products, and Storage & Management.
  • Based on Technology, market is studied across Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing By Synthesis, and Single-Molecule Real-Time Sequencing.
  • Based on Application, market is studied across De Novo Transcriptome Assembly, Expression Profiling Analysis, Small RNA Sequencing, and Variant Calling & Transcriptome Epigenetics.
  • Based on End-User, market is studied across Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research & Academia.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in the adoption of next-generation sequencing
      • 5.1.1.2. Robust growth of precision medicines and rising amount of RNA sequencing grants
      • 5.1.1.3. Increasing demand for advanced sequencing-based diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Cost of NGS instruments is high
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the RNA-Sequencing
      • 5.1.3.2. Increasing research activities related to RNA-Sequencing
    • 5.1.4. Challenges
      • 5.1.4.1. Unavailability of skilled manpower
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. NGS-Based RNA-Sequencing Market, by Product & Services

  • 6.1. Introduction
  • 6.2. Data Analysis
  • 6.3. RNA Sequencing Platforms & Consumables
  • 6.4. RNA Sequencing Services
  • 6.5. Sample Preparation Products
  • 6.6. Storage & Management

7. NGS-Based RNA-Sequencing Market, by Technology

  • 7.1. Introduction
  • 7.2. Ion Semiconductor Sequencing
  • 7.3. Nanopore Sequencing
  • 7.4. Sequencing By Synthesis
  • 7.5. Single-Molecule Real-Time Sequencing

8. NGS-Based RNA-Sequencing Market, by Application

  • 8.1. Introduction
  • 8.2. De Novo Transcriptome Assembly
  • 8.3. Expression Profiling Analysis
  • 8.4. Small RNA Sequencing
  • 8.5. Variant Calling & Transcriptome Epigenetics

9. NGS-Based RNA-Sequencing Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Pharmaceutical & Biotechnology Companies
  • 9.4. Research & Academia

10. Americas NGS-Based RNA-Sequencing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific NGS-Based RNA-Sequencing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa NGS-Based RNA-Sequencing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies
  • 2. Becton, Dickinson and Company
  • 3. BGI Group
  • 4. Eurofins Scientific
  • 5. F. Hoffmann-la Roche AG
  • 6. Genewiz by Brooks Automation, Inc.
  • 7. Hamilton Company
  • 8. Illumina, Inc.
  • 9. Merck KGaA
  • 10. Oxford Nanopore Technologies
  • 11. PerkinElmer, Inc.
  • 12. Psomagen
  • 13. Qiagen N.V.
  • 14. Takara Bio Inc.
  • 15. Thermo Fisher Scientific

LIST OF FIGURES

  • FIGURE 1. NGS-BASED RNA-SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 2. NGS-BASED RNA-SEQUENCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NGS-BASED RNA-SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NGS-BASED RNA-SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NGS-BASED RNA-SEQUENCING MARKET DYNAMICS
  • TABLE 7. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING PLATFORMS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STORAGE & MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DE NOVO TRANSCRIPTOME ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY EXPRESSION PROFILING ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SMALL RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY VARIANT CALLING & TRANSCRIPTOME EPIGENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. NGS-BASED RNA-SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023